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Antimony compounds  have been employed medicinally for over 4,000 years.  In 
Roman times antimony-rich vessels were used to store wine which was then drunk to 
induce vomiting;  while in  the  middle ages  antimony was  employed as  a  panacea 
against  the  plague.  In  recent  times  antimony  compounds  have  been  employed 
therapeutically  against  a  number  of parasitic  diseases  including  trypanosomiasis, 
leishmaniasis, bilharziasis, and schistosomiasis (1). 
Both tri- and pentavalent antimony compounds have been administered for par- 
asiticidal effects; however the former have proved more effective, probably because 
they are freely transferable through the erythrocyte membrane whereas the pentava- 
lent forms are not  (2).  In circulating blood antimony is removed extremely rapidly, 
partly because of its rapid excretion in the urine  (especially the pentavalent  form) 
and partly because of its uptake by different body tissues (2). This has resulted in the 
administration of antimony over extended time periods, lasting many weeks, in the 
treatment of parasitic diseases (3). Liver injury, manifested by fatty degeneration (4) 
and jaundice (5), has been associated with such prolonged antimony treatment. 
Recent studies from this laboratory have demonstrated that a number of transition 
elements and  heavy metals  (6-8)  are capable of increasing the de  novo  synthesis of 
heme oxygenase, the rate-limiting enzyme in  the oxidative metabolism of heme to 
bile pigment  (9,  10).  Included among the metals that  are potent inducers of heine 
oxygenase are environmental pollutants such as tin (11), cobalt (8), cadmium (8), and 
platinum (12) and metals such as gold (13) and iron (8), which are used therapeutically 
in man. Because of the extensive use of antimony as a parasiticidal, agent, it seemed 
of interest to assess the ability of this metal and also of antimony-containing drugs to 
induce heine oxygenase. The results of this study show that trivalent antimony is an 
extremely potent inducer of heme oxygenase in liver and kidney, whereas pentavalent 
antimony is a poor inducer of this enzyme. Antimony-containing parasiticidal agents 
also greatly enhance the rates of heme degradation in these tissues, 
Materials and Methods 
Materials.  Male Sprague-Dawley  rats, 175-225 g, purchased from Holtzman Co., Madison, 
Wis. were used throughout this study. All antimony salts were purchased from Fisher Scientific 
Co.,  Pittsburgh,  Pa.,  except  antimony  sodium  dimercaptosuccinate, which  was  a  gift  of 
Hoffmann-La Roche, Inc., Nutley, N. J.  Antimony sodium dimercaptosuccinate (Astiban), 
antimony potassium tartrate (tartar emetic) and antimony sodium gluconate (Pentostam)  were 
the parasiticidal  agents examined in this study. All other chemicals were purchased from Sigma 
Chemical Co., St. Louis, Mo. 
* Supported by grant ES-01055  from the U. S. Public Health Service. 
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Treatment of Animals.  Rats were injected at subcutaneous sites with either zinc or cobalt 
chloride and a variety of antimony salts at doses up to 250 #mol/kg. Control rats received an 
equivalent volume of normal saline. Desferoxamine mesylate (Desferal mesylate; Ciba-Geigy 
Corp., Summit, N. J.) which is used therapeutically to chelate iron was injected intraperitoneally 
at a  dose of 1 gm/kg. The rats were permitted water but were starved for  16 h  after metal 
administration before being killed by decapitation. Livers were perfused in situ with ice-cold 
saline and were then removed and homogenized, as were other tissues, in 3 vol 0.1 M potassium 
phosphate, pH 7.4, containing 0.25 M  sucrose. The homogenate was centrifuged at 9,000 g for 
20  min. The precipitate was washed twice with 0.1  M  potassium phosphate, pH  7.4, before 
assaying for 8-aminolevulinate synthase (ALAS)  I aetivity. The 9,000-g supernate was centri- 
fuged at 100,000 g for 60 min; the cytosol was employed as a source of biliverdin reductase; and 
the mierosomal pellet was washed once with and resuspended in 0.1  M  potassium phosphate 
buffer, pH 7.4. 
Assays 
ENZYME ACTIVITIES.  The activities of ALAS (14),  aniline hydroxylase (15),  ethylmorphine 
demethylase (7), and heme oxygenase (16) were assayed as previously described. The formal- 
dehyde produced in  the ethylmorphine demethylase assay was measured by the method of 
Nash (17). Bilirubin produced in the heme oxygenase assay was calculated using an extinction 
coefficient of 40 mM -1 cm  -t between 464 and 530 nm. 
PROTEIN ASSAY.  Protein concentration was determined by the method of Lowry (18) using 
crystalline bovine serum albumin as standard. 
SPECTRAL STUDIES.  Cytochrome P-450 was measured using sodium dithionite as a reducing 
agent and using an  extinction coefficient of 91  mM  -1 cm  -x between 450 and 490 nm  (19). 
Microsomal heme  concentration was  determined by the  pyridine hemochromogen  method 
using an extinction coefficient of 20.7 mM -1 cm  -1 between 557 and 540 nm (20). An Aminco- 
Chance DW2A spectrophotometer (American Instrument Go., Silver Spring, Md.) in the split 
beam mode was employed for the spectral studies. 
Statistical Analysis.  The data were analyzed by the standard t test and the value of P <  0.05 
was regarded as denoting significance. 
Results 
Dose-Response  Curves  of  Antimony  Induction  of  Heme  Oxygenase  in  Liver  and 
Kidney.  Trivalent antimony was  found to be an extremely potent  inducer of heine 
oxygenase in  liver (Fig. 1).  At  an  antimony  dose of 25/~mol/kg  (3.0  mg/kg)  heine 
oxygenase activity was  increased fivefold when  measured at  16  h;  by comparison a 
comparable  induction  of the  enzyme  requires  severalfold larger  amounts  of other 
inducing metals  (8, 21).  A  maximum  induction effect, (10-fold greater than control 
levels), was achieved with an antimony dose of 125/~mol/kg (15.0 mg/kg). Adminis- 
tration of pentavalent antimony also increased hepatic heme oxygenase activity, but 
the  maximum  levels obtained  were  threefold  higher  than  control  levels and  were 
reached only after administration of a  substantially higher (250 #mol/kg) dose of the 
metal. The dose-response of heme oxygenase induction in kidney (Fig.  1) to trivalent 
antimony administration was strikingly similar to that in liver in that enzyme levels 
were markedly increased at the lowest levels of antimony administered and reached 
a  maximum of ~11-fold above control levels at a  dose of 125 #mol/kg.  Pentavalent 
antimony  was  not  a  potent  inducer  of  heine  oxygenase  in  kidney,  a  maximum 
induction of 1.5-fold being obtained at a  dose of 125/~mol/kg (Fig.  1). 
Time-Course of Trivalent Antimony Induction of  Heme Oxygenase and Concomitant Perturbations 
of Heine Metabolism  in Liver and Kidney.  The levels of heme oxygenase in liver did not 
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Fzo,  1.  The  dose-response  curve  of  tri-  and  pentavalent  antimony  administration on  heme 
oxygenase induction in liver and kidney. The animals (four to six per point) were treated with the 
metal chlorides as described in Materials and Methods. 
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Flo.  2.  The time-course of response in liver to trivalent antimony chloride administered at a dose 
of 250/maol/kg. Assays were carried out as described in Materials and Methods.  Three animals 
were used at each time point. 
increase significantly during the first  3 h  after antimony administration, but by 5  h 
there  was  a  rise  of  more  than  twofold  (Fig.  2).  The  enzyme  activity  increased 
dramatically thereafter, reaching a maximum at 16 h ~ 10-fold higher than the initial 
level  and remaining  highly elevated  at  24 h. ALAS  activity  decreased  by 30%  1 h 
after antimony administration.  This enzyme activity  remained  depressed  up to 8  h 
before  exhibiting a  rebound  increase  in activity  at  16  h  similar  to that  previously 
described  with cobalt  administration  (7).  This  elevated  level  of ALAS  activity was 
then maintained  through the 24-h time period.  The level of cytochrome  P-450  did 
not change significantly until 8 h  after antimony administration when a decrease of 
18% was evident; by  16 h  the cytochrome P-450 level had decreased by almost 40%. 
Microsomal  heine  levels  exhibited  similar  changes  (data  not  shown).  The  level  of 
cytochrome  P-450  remained  low  at  24  h  despite  the  increased  level  of  ALAS; 
presumably  this was  because  heme  oxygenase activity  was still some  10-fold above 
normal  at  this  time.  Concomitant  with  the  low  cytochrome  P-450  level,  aniline 
hydroxylase  activity  was  decreased  by almost  40%  at  16  h;  cytochrome  b5 content 
remained  unchanged  (results  not  shown)  probably  because  of its  long  half-life  in 
contrast  to that  of cytoehrome  P-450.  In  kidney,  heine oxygenase  activity  did  not 
change  significantly  during the initial  3  h  after  antimony  administration  (Fig.  3); 
however, the enzyme level had doubled by 5 h and continued to rise rapidly reaching 248  HEME-DEGRADING ACTION  OF ANTIMONY 
a: 
.c_ 
a) 
E 
o 
3 
.o 
"6 
E 
c 
150 
10.0 
50 
0  5  I0  15  20  25 
Time (h) 
1,5 
1,0 
0.5 
o 
x 
a~ 
.~  O. 
~E 
a3 
~E  Eo 
<o 
EE 
~c 
Fro.  3.  The tinie-course  of response to trivalent antimony chloride in kidney. The conditions were 
identical to those described in Fig. 2. 
TABLE  I 
Effect of Trivalent Antimony on Heme Oxygenase and ALAS Activity 
In  Vitro 
Antimony 
Heine oxygenase 
activity (nmol 
bilirubin formed/ 
mg protein per h) 
ALAS activity 
(nmol ALA formed/mg 
protein per h) 
Liver  Kidney  Liver  Kidney 
mM 
0  2.67  1.04  0.110  0.086 
0.10  2.89  1.70  0.048  0.084 
0.25  2.89  1.51  0.038  0.066 
0.50  3.02  1.47  0.037  0.063 
1.00  2.95  1.17  0.029  0.042 
Heme oxygenase and  ALAS were prepared and  assayed as  described in 
Materials and Methods. The assays were done in duplicate and are the average 
of three experiments. 
a  maximum 10-fold higher than the initial level by  16 h.  High levels of renal heme 
oxygenase were maintained for at  least  24 h  after antimony administration. ALAS 
activity in kidney dropped sharply after antimony administration and did not return 
to the control level until 8 h, after which the enzyme activity reached a  level twofold 
higher than control at  16 h  and almost threefold higher at 24 h. Cytochrome P-450 
content remained constant for the initial 5 h  before decreasing by 30% at  16 h. 
Effect  of  Trivalent  Antimony  In  Vitro  on  Heine  Oxygenase  and  ALAS.  A  series  of 
concentrations (up to 1 mM) of trivalent antimony were tested in vitro for their effect 
on heme oxygenase and ALAS activities isolated from  liver and kidney (Table I). 
Antimony _<1  mM had no effect on hepatic heme oxygenase activity in vitro, but 0.1 
mM  antimony increased  renal  heine  oxygenase  activity  by  60%;  this  increase  in 
activity declined with  increasing antimony concentration, although at  1 mM  anti- 
mony renal heine oxygenase activity was still greater than the control level. In vitro 
antimony, even at a concentration of 0.1 mM, was a potent inhibitor (~60%) of ALAS 
activity isolated from liver; inhibition  of ALAS activity was significantly  greater with 
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TABLE  II 
Effect of Various Antimony Salts on Heme Oxygenase Induction and the Concomitant Perturbations in Heme 
Metabolism in Liver 
Heme oxygen-  Ethylmor-  Aniline hy- 
ase (nmol bili-  ALAS (nmol  phine demeth-  droxylase 
rubin formed/  ALA/mg  Cytochrome  Microsomal 
P-450  heine  ylase (/tanol/  (nmol p-ami- 
mg protein  protein per h)  mg protein  nophenol/mg 
per h)  per h)  protein per h) 
nmoi  /mg  nmol/mg 
Saline  2.52 ~  0.14  0.170 2:0,01  0.73:1:0,03  I.(54:1:0.06  0.408 ±  0.06  98.28 :t: 7.22 
Antimony*  trichloride  15.35 ±  0,92:~  0,295 ±  0,02:~  0.54 :t: 0.01~  [.39 :t: 0.04:~  0.253 ±  0~04:~  75.26:1:5.01 
Antimony*  potassium tartarate  10,57 :l: 1.95:~  0,478 ±  0.05~:  0.47 :l: 0.03~  1.24 ±  0.07~:  0.205:1: 0.04:~  48.70 ±  4.13~ 
(tartar emetic) 
Antimony*  sodium  dimercaptosuc-  9.53:1: 0.20~  0.378 :t: 0.05~:  0.66 ±  0.0[  1.54 ±  0.0l  0.419 ~: 0.05  91.20 :t: 8.01 
clnate (Astiban) 
Antimony pentachlorlde  4.67 ±  0.36~  0.17B ±  0.08  0.70 ±  0.04  1.48 ±  0.04  0.412 ~  0.05  98.28 ~  1.11 
Sodium stiboglueonate (Pentostam)  2.58 :t: 0.44  0,155 ±  0,02  0.73 ±  0.01  1.58 ±  003  0.392 ±  0.06  97.39 +  8,14 
The concentration  of antimony  used  was B2 pmol/kg  (10 mg/kg), The animals  (four to six  per compound)  were treated  as described  in 
Materials and Methods. 
* Trivalent antimony. 
P <  0.05, significantly different from the control value. 
TABLE III 
Effect of Blocking Agents on Antimony and Cobalt Induction of Heme Oxygenase and 
Associated Perturbations in ALAS Activity and Cytochrome P-450 Content 
Heme oxygenase  ALAS (nmol  Cytochrome 
Treatment  (nmol bilurubin/  ALA/mg protein  P-450 
mg protein per h)  per h) 
nmol/mg 
Saline  2.66 ± 0.13  0.154 ±  0.03  0.69 ~  0.05 
Sb  3+  17.23 +  1.92  0.297 +  0.03  0.39 :t: 0.03 
Sb  3+ q- Zn  2+  14.33 ±  1.12  0.311 ±  0.04  0.43 "4- 0.05 
Sba+-cysteine complex  17.97 +  1.28  0.214 ± 0.01  0.33 ± 0.03 
Cysteine (oral) before Sb  n+  26.22 ±  0.86  0.252 ± 0.02  0.34 ± 0.02 
Co  2+  13.87 ± 0.66  0.593 ± 0.05  0.48 + 0.04 
Co  2+ +  Zn  2+  7.68 ± 0.88*  0.365 ±  0.03*  0.53 ±  0.06 
Co2+-cysteine complex  2.63 +  0.33*  0.293 ±  0.02*  0.68 ± 0.02* 
Cysteine (oral) before Co  2+  3.18 ± 0.25"  0.185 ± 0.05*  0.72 :tz 0.02* 
The concentration of antimony, cobalt, and zinc chlorides  used was 250 ~mol/kg. Cysteine 
(1-2 ml of a  1 M solution)  was administered by gavage  15 rain before the inducing metal. 
The metals were complexed with cysteine at a molar ratio of 1:4 for subcutaneous adminis- 
tration as a complex. 
* P <  0.05, significantly different from the control value. 
Effects of Various Tri- and Pentavalent  Salts of Antimony on Heme Oxygenase Induction  and 
Associated  Parameters  of Heme  Metabolism  in  Liver.  The  antimony  salts,  including 
parasiticidal agents, examined were administered to rats at a  dose of 10 mg antimony/ 
kg  which  is  in  the  dose range  generally employed  therapeutically in  humans.  It  is 
evident from Table II that trivalent antimony salts, including two of the parasiticidal 
drugs  tested,  are  potent  inducers of heme  oxygenase in  liver,  whereas  pentavalent 
antimony  salts  are  not.  This  effect  appears  independent  of  the  salt  employed. I 0.0 
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TABLE  IV 
Effect of Desferoxamine on Perturbations in Heine Metabolism Produced by Antimony and 
Cobalt 
Heine oxy-  ALAS (nmol 
genase (nmol  ALA/mg pro-  Cytochrome  Microsomal 
Treatment  bilirubin/mg  P-450  heme 
protein per h)  rein per h) 
nmol/mg  nmol/mg 
Saline  2.42 +  0.20  0.163  +  0.01  0.89 4- 0.03  1.92 4- 0.04 
Desferoxamine  3.89 4- 0.31  0.186 +  0.03  0.76 4- 0.04  1.66 4- 0,05 
Sb  a+  9.37 +  0.32  0.458  +  0.03  0.75 4- 0.04  1.71 +  0.06 
Sb  s+ +  desferoxamine  7.00 +  0.28  0.188  +  0.02*  0,64 +  0.04  1.53 +  0,06 
Co  2+  16.05 4- 0.80  0.425 4- 0.02  0.68 4- 0.03  1.53 4- 0,04 
Co  2÷ +  desferoxamine  15.11 4- 1.07  0.200 4- 0.02*  0.47 +  0.04*  1.12 4- 0.05* 
Antimony was administered subcutaneously as sodium dimercaptosuccinate at a concentra- 
tion of 82 #mol/kg (10 mg/kg). Cobalt was administered as COC12.6H~O subcutaneously at 
a concentration of 250 #mol/kg, Desferoxamine was administered intraperitoneally at a dose 
of 1 gm/kg. 
* P <  0.05, significantly different from the control value. 
Associated with the induction  of heme  oxygenase was a  significant increase in ALAS 
activity  as  measured  at  16  h  (see  Fig.  2).  This  represents  the  rebound  increase  in 
ALAS  shown  in  Fig.  2  and  previously  reported  as  a  late  enzyme  response  to other 
inorganic  metals  (7,  12).  The  levels  of  cytochrome  P-450  and  microsomal  heme 
decreased concomitantly  with the increased levels of heine oxygenase, although  these 
changes were more pronounced  with the chloride and  the potassium  tartarate  salts of 
trivalent  antimony  than  with  the  sodium  dimercaptosuccinate  salt.  Similarly,  the 
decreases  in  cytoehrome  P-450-dependent  ethylmorphine  demethylase  and  aniline 
hydroxylase activities were most evident after administration  of antimony  trichloride 
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In kidney, trivalent salts including the trivalent antimony parasiticidal agents were 
also more potent inducers of heme oxygenase than the pentavalent salts (Fig.  1). This 
effect was independent of the salt used. The other perturbations in heine metabolism 
were similar to those described for liver. 
Effect  of Cysteine and Zinc on Heme  Oxygenase Induction by Antimony and Cobalt.  Both 
trivalent antimony and divalent cobalt are potent inducers of heme oxygenase in liver 
(Figs.  1 and  2  and Table III). Administration  of cysteine by gavage or as cysteine 
complexed with antimony did not prevent heine oxygenase induction or the concom- 
itant  decrease  in  cytoehrome P-450  levels and  the  changes  in  ALAS  activity. The 
changes  in  heme  metabolism  associated  with  cobalt  in  vivo  were  prevented,  as 
previously described  (8), by either pretreatment with cysteine or administration of a 
cysteine  cobalt  complex  under  identical  conditions  to  those  used  for  antimony. 
Similarly, zinc has been shown to substantially block the induction of heme oxygenase 
in  liver by cobalt  (22).  However zinc was unable  to block the antimony-mediated 
induction  of heme oxygenase in  liver and  the  concomitant  perturbations  in  heme 
metabolism (Table III). 
Dose-Response of Various Parameters of Heme Metabolism to Antimony Sodium Dimercapto- 
succinate (Astiban)  in Liver.  Heme oxygenase activity increased with increasing con- 
centration of this antimony derivative when measured 16 h after metal administration 
(Fig. 4). A dose of 5 mg/kg antimony resulted in an almost twofold increase in enzyme 
activity, whereas  a  dose of 20 mg/kg caused  an  ~fourfold increase.  ALAS activity 
exhibited  a  similar  dose-response  reflected  in  increased  ALAS  activity  at  16  h 
associated with  increasing  dose of metal administered.  Levels of cytochrome P-450 
declined  with  increasing  amounts  of antimony,  as  did  ethylmorphine  demethylase 
activity. A similar series of changes was observed in kidney (data not shown). 
Effect  of Desferoxamine (Desferal  Mesylate)  on  Various Parameters of Heine Metabolism 
Mediated  by  Antimony  and  Cobalt.  Trivalent  antimony  (10  mg/kg)  induced  hepatic 
heme oxygenase almost fourfold above control  level  (Table IV). Concomitant  with 
this increase in heine oxygenase was a substantial rebound increase in ALAS at  16 h 
(Table IV). Simultaneous administration of desferoxamine did not markedly alter the 
extent of heine oxygenase induction by antimony, but completely blocked the rebound 
increase in ALAS. The decreases in levels of cytochrome P-450 and microsomal heme 
on antimony administration were more pronounced on simultaneous desferoxamine 
treatment. Identical results were observed with cobalt in that desferoxamine did not 
block heine oxygenase induction, but prevented the rebound increase of ALAS activity 
and, in addition,  further lowered the contents of cytochrome P-450 and microsomal 
heme. 
Discussion 
This  study  demonstrates  that  antimony  and  antimony-containing  parasiticidal 
agents have a  potent  ability to  induce  the microsomal enzyme heme oxygenase in 
both liver and kidney  (Fig.  1 and Table II) and, consequently, to enhance the rates 
of heine degradation in these tissues. The potent ability of trivalent antimony to alter 
these aspects of heine metabolism is independent of the salt used (Table II) and does 
not appear from in vitro studies to be a  direct activation of the enzyme. The extent 
of enzyme induction in liver is comparable to that produced by cobalt, but is obtained 252  HEME-DEGRADING ACTION OF ANTIMONY 
with a dose one-half that reported for the latter element (6). Pentavalent antimony is 
a weak inducer of heme oxygenase in both organs studied (Fig.  1). 
Associated  with  the  increase  in  heme  oxygenase activity produced  by trivalent 
antimony is a substantial decrease in cytochrome P-450 (Figs.  2 and 3 and Table II) 
and heme contents (Table II) and a marked decrease in the activities of  the cytochrome 
P-450-dependent drug metabolizing enzymes ethylmorphine demethylase and aniline 
hydroxylase (Table II). The sequential changes--an initial inhibition and a rebound 
increase in  ALAS activity--that usually occur with  cobalt  administration  (7)  also 
occur after antimony administration (Figs. 2 and 3). Thus, trivalent antimony through 
its potent heme oxygenase-inducing action leads to deleterious perturbations in heme 
metabolism reflected in significant impairment of the cytochrome P-450-dependent 
mixed function oxidase system. 
The potent ability of trivalent as compared with pentavalent antimony to induce 
heme oxygenase is of interest  because trivalent  antimony compounds have proved 
more effective than pentavalent  antimony compounds as parasiticidal  agents  (23). 
The  reason  for  this  is  not  clear  but  trivalent  compounds  tend  to  concentrate  in 
erythrocytes, whereas pentavalent compounds do not; high levels of both forms are 
present in the plasma and are thought to be bound to plasma proteins (2). Trivalent 
antimony passes freely through the erythrocyte membrane (2) and as such may be the 
more available form of antimony. 
The normal therapeutic use of antimony compounds involves a series of injections 
generally lasting several weeks in duration (3). In this study, a single dose, in animals, 
of the usual  single therapeutic dose  (10 mg/kg)  of trivalent antimony in man was 
shown to produce a four- to sixfold increase in hepatic heme oxygenase activity (Table 
II). Repeated administration of antimony would thus be expected to lead to sustained 
high levels of heine oxygenase activity (7) and prolonged decreases in cellular contents 
of cytochrome P-450 and other hemoproteins (7,  11).  Thus the intensive antimony 
therapeutic  regimens  employed in  man  could  be  seriously detrimental  to  certain 
heme-dependent  cellular  functions  in  the  absence  of adaptive  or  compensatory 
mechanisms which would minimize the toxicity of the metal. 
There exist several possible defense mechanisms against the toxic effects of metals 
on heme metabolism.  We have shown that  complexing metals with giutathione or 
cysteine in  vitro or administration  of cysteine by gavage protect against  the toxic 
effects of cobalt, nickel, and platinum on heme metabolism  (8, 24).  Manganese  in 
kidney and  zinc  in  liver and  kidney when  administered  either simultaneously  or 
before a  heme-oxygenase-inducing metal have been shown to reduce or abolish the 
metal-mediated induction of the enzyme and the associated decreases of cellular heme 
and  hemoprotein  contents  (22).  However, antimony-mediated  induction  of heme 
oxygenase  as  shown  in  this  study  was  not  prevented  either  by  the  simultaneous 
administration of zinc or by the use of cysteine in vitro or in vivo (Table III). Cobalt 
induction of heme oxygenase by comparison was largely blocked by zinc treatment 
and  entirely blocked  by  cysteine treatment  (Table  III).  The  explanation  for  the 
inability of either zinc or cysteine to block antimony induction of heme oxygenase is 
not evident, but the finding, with cysteine, is of particular interest because dimethyl- 
cysteine is known to reduce the toxic, but not the therapeutic, effects of drugs that 
contain arsenic and antimony (25).  Arsenic, like antimony, induces heme oxygenase 
in both liver and kidney (data not shown). GEORGE  S.  DRUMMOND  AND  ATTALLAH  KAPPAS  253 
It was of interest that both in the case of antimony and cobalt, desferoxamine, a 
chelator of trivalent metals, especially iron, was unable to significantly diminish the 
induction of heme oxygenase but almost entirely prevented the late rebound increase 
in  ALAS  activity  (Table  IV)  caused  by both  elements.  These  findings  raise  the 
possibility that  iron, released  during the metal-induced  heme degradation  process 
may, as has been shown in vivo (26), participate in a synergistic induction process for 
ALAS in some manner,  thus accounting,  in part,  for the rebound increase of this 
enzyme. This rebound takes place when the original inducer metal has presumably 
been  excreted  from  the  liver or  kidney and  thus  cannot  continue  to  repress  the 
synthesis of ALAS (21). However, it should be noted that iron itself not only induces 
heme oxygenase (8, 27), but also produces the early transient decline in ALAS activity 
associated with the induction of heine oxygenase by many other metals such as cobalt 
or antimony. 
Parasiticidal  therapy with  antimony compounds  is  generally prolonged  (3)  and 
jaundice frequently occurs (5); the duration of treatment can in some instances extend 
for >25 wk (28)  at high doses of the metal-containing drugs. It is possible therefore 
that the jaundice described during such extensive treatment periods results not only 
from  direct hepatocellular toxicity but  also,  in  part,  from the  long sustained  and 
marked enhancement of heme degradation mediated by the antimony in the para- 
siticidal agent. The cellular depletions of heine and hemoproteins, which could occur 
during such prolonged therapeutic regimens, would be expected to impair significantly 
those  cellular  functions  dependent  on  respiratory cytochromes and  the  chemical 
detoxification processes known to be dependent on an intact cytochrome P-450 system. 
These effects of antimony  resulting  from  prolonged induction  of heine oxygenase 
would have such deleterious effects if the actions of the metal on the enzyme could 
not be blocked or if the perturbation of heine metabolism could not be compensated 
by some mechanism, perhaps similar to that we have described in chronic, genetically 
dependent  hemolysis in  mice homozygous for the nb  (normoblastosis)  gene, i.e., a 
marked and sustained increase in heme synthetic activity (14). 
The  mechanism  of the  parasiticidal  action  of antimony  has  not  been  entirely 
clarified, but is thought to be a  result of a  preferential uptake of the metal by the 
parasite resulting in an inhibition of anaerobic glycolysis--specifically at the site of 
phosphofructokinase activity (29). The studies described here indicate that antimony 
is also a potent inducer of the enzyme heme oxygenase, and as a consequence of this 
action, can substantially increase the rate of heine degradation. The relation between 
these distinct biochemical actions of antimony is not known. 
Heine has been shown to be essential for the growth of certain trypanosomatidae 
(30).  Cytochromes a3 and o have been reported in cultured forms of Ttypanosoma mega 
(31), cytoehromes aan, b, and c in T(ypanosoma brucei (32), and an inducible eytochrome, 
P-450, has been described in  Toppanosoma cruzi (33).  In  Crithidia lucilia, eatalase has 
been proposed to act as a reservoir for heme (34).  If the heme-degradative actions of 
drugs  containing  antimony  and  arsenic  have  some  relation  to  their  parasiticidal 
actions, then it might be useful to examine other metals or metalloporphyrins which 
can markedly degrade heine through prolonged induction of heme oxygenase (35, 36) 
for possible parasiticidal effects. 
Summary 
The ability of antimony and antimony-containing parasiticidal agents to enhance 
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was shown to be an extremely potent inducer of heme oxygenase, the initial and rate- 
limiting enzyme in heine degradation, in both organs, whereas the pentavalent form 
was a weak inducer of this enzyme. The ability of antimony to induce heme oxygenase 
was  dose-dependent,  independent  of  the  salt  used,  and  not  a  result  of  a  direct 
activation of the enzyme in vitro. Concomitant with heine oxygenase induction  by 
antimony,  microsomal heme  and  cytochrome  P-450  contents  decreased,  the  cyto- 
chrome P-450-dependent  mixed function  oxidase system was impaired,  and 6-ami- 
nolevulinate synthase (ALAS), the rate-limiting enzyme of heine synthesis, underwent 
the  sequential  changes--initial  inhibition  followed by rebound  induction--usually 
associated with the administration of transition elements such as cobalt. 
Antimony  induction  of heine  oxygenase  however,  unlike  the  enzyme  induction 
elicited  by cobalt, was not prevented either by cysteine administered orally or as a 
cysteine metal complex, or by simultaneous zinc administration. Desferoxamine also 
did not block heme oxygenase induction by antimony, but this chelator did prevent 
the rebound increase in ALAS activity associated with antimony or cobalt treatment. 
Antimony-containing parasiticidal drugs were also potent  inducers  of heine oxy- 
genase  in  liver  and  kidney.  The  heme  degradative  action  of these  drugs  may  be 
related in part to the jaundice commonly associated with the prolonged therapeutic 
use of these agents. 
The heme-oxygenase-inducing action of antimony-containing parasiticidal drugs is 
a  newly defined biological property of these compounds.  The relation between  the 
parasiticidal  and  the  heme-oxygenase-inducing actions  of such  drugs  is  unknown. 
However, certain parasites contain hemoproteins or require heine compounds during 
their life cycle. It may therefore be useful  to explore the possibility that  the heine- 
degrading and the parasiticidal actions of certain metals or metal-containing thera+ 
peutic agents are in some way related. 
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